Full Access
Neuropsychological deficits in adults with Neurofibromatosis type 1
M. E. T. Zöller,
B. Rembeck,
L. Bäckman,
Corresponding Author
M. E. T. Zöller
Department of Clinical Neuroscience, Sections of Psychiatry, Göteborg, Sweden
Dr Madeleine Zöller, Department of Psychiatry, Mölndal Hospital, S-431 80 Mölndal, SwedenSearch for more papers by this authorB. Rembeck
Department of Clinical Neuroscience, Sections of Psychiatry, Göteborg, Sweden
Search for more papers by this authorL. Bäckman
Department of Psychology, Göteborg University, Göteborg, Sweden
Search for more papers by this authorM. E. T. Zöller,
B. Rembeck,
L. Bäckman,
Corresponding Author
M. E. T. Zöller
Department of Clinical Neuroscience, Sections of Psychiatry, Göteborg, Sweden
Dr Madeleine Zöller, Department of Psychiatry, Mölndal Hospital, S-431 80 Mölndal, SwedenSearch for more papers by this authorB. Rembeck
Department of Clinical Neuroscience, Sections of Psychiatry, Göteborg, Sweden
Search for more papers by this authorL. Bäckman
Department of Psychology, Göteborg University, Göteborg, Sweden
Search for more papers by this authorAbstract
Objectives – To examine neuropsychological deficits in adults with Neurofibromatosis type 1 (NF1) with and without an affective mental disorder (i.e. dysthymia). Material and methods – Seventy adult NF1 patients were followed-up after a 12-year period. Of 65 patients assessed earlier with the Comprehensive Psychopathological Rating Scale (CPRS), 19 patients had died. The remaining patients were assessed by the CPRS with the exception of 4 patients, and were psychiatrically diagnosed according to DSM III-R. Twelve patients were excluded because of advanced age, and psychiatric illness other than affective disorder. The remaining 30 NF1 patients (7 with affective disorder and 23 psychiatrically healthy), and a control group of 23 normal adults were assessed on a variety of neuropsychological tests. Results – Results indicated NF1-related deficits in inductive reasoning, visuoconstructive skill, visual and tactual memory, logical abstraction, coordination, and mental flexibility, although basic motor speed and vocabulary were not affected by NF1. An affective disorder exacerbated the neuropsychological deficits associated with NF1 only with regard to tests assessing motor functions. Conclusions – NF1 results in a relatively global cognitive impairment among adults, and additional depressive symptoms appear to slow down basic motor processes. It was speculated that the NF1-related cognitive deficits may partly result from white-matter lesions in subcortical brain areas, due to proliferation of glial tissue, aberrant myelination or hamartomas.
Reference
- 1 Riccardi VM. Von Recklinghausen neurofibromatosis. N Eng J Med 1981: 305(27): 1717–27.
- 2 Huson SM, Harper PS, Compston DAS. Von Recklinghausen neurofibromatosis: a clinical and population study in South-East Wales. Brain 1988: 11: 1355–81.
- 3 Riccardi VM, Lewis RA. Penetrance of von Recklinghausen neurofibromatosis: a distinction between predecessors and descendants. Am J Hum Genet 1988: 42: 284–9.
- 4 Crowe FW, Schull WJ, Neel JV. A clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield: Charles C Thomas, 1956.
- 5 Wander JV, Das Gupta TK Neurofibromatosis. Curr Probl Surg 1977: 14: 1–81.
- 6 Wallace MR, Marchuk DA, Andersen LB, Letcher R, Odeh HM, Saulino AM. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients. Science 1990: 249: 181–6.
- 7 Cawthon RM, Weiss R, Xu G, Viskochil D, Culver M, Stevens J. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990: 62: 193–201.
- 8 Marchuk DA, Saulino AM, Tavakkol R, et al. cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of the NF1 gene product. Genomics 1991: 11: 931–40.
- 9 Viskochil D, Buchbero AM, Xu G et al. Deletions and translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990: 62: 187–92.
- 10 Legius E, Marchuk DA, Collins FS, Glover TW. Somatic deletion of the neurofibromatosis type 1 gene in a neurofibrosarcoma supports a tumour suppressor gene hypothesis. Nat Genet 1993: 3: 122–6.
- 11 National Institute of Health Consensus Development Conference Statement. Neurofibromatosis conference statement. Arch Neurol 1988: 45: 575–8.
- 12 Samuelsson B, Samuelsson S. Neurofibromatosis in Gothenburg, Sweden. 1. Background, study design and epidemiology. Neurofibromatosis 1989: 2: 84–106.
- 13 Zöller ME, Rembeck B, ÅKesson HO, Angervall L. Life expectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Göteborg, Sweden. Acta Derm Venereol 1995: 75: 136–40.
- 14 Sörensen SA, Mulvihill JJ, Nielsen A. On the natural history of von Recklinghausen neurofibromatosis. Ann NY Acad Sci 1986: 486: 30–7.
- 15 Preiser SA, Davenport CB. Multiple neurofibromatosis (von Recklinghausen's disease) and its inheritance. Am J Med Sci 1918: 156: 507–41.
- 16 Samuelsson B. Neurofibromatosis (von Recklinghausen's disease). A clinical psychiatric, and genetic study. Thesis. University of Göteborg, 1981.
- 17 Riccardi VM. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore: The Johns Hopkins University Press, 1992.
- 18 Eliason MJ. Neuropsychological patterns: neurofibromatosis compared to developmental learning disorders. Neurofibromatosis 1988: 1: 17–25.
- 19 Varnhagen CK, Lewin S, Das J. Neurofibromatosis and psychological processes. J Dev Behav Pediatr 1988: 5: 257–65.
- 20 Wadsby M, Lindehammar H, Eeg-Olofsson O. Neurofibromatosis in childhood: neuropsychological aspects. Neurofibromatosis 1989: 2: 251–60.
- 21 Mouridsen SE, Sörensen SA. Psychological aspects of von Recklinghausen neurofibromatosis (NF1). J Med Genet 1995: 32: 921–4.
- 22 Bellerman P. What is it like to have a learning disability? Achieving in spite of…. Florida: National Neurofibromatosis Inc. 1989: 4–13.
- 23 Ferner RE. Intellect in neurofibromatosis 1. In: SM Huson, RAC Hughes, eds. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman and Hall. 1994: 233–53.
- 24 Aron AM, Rubenstein AE, Wallace SA, Halperin JC. Learning disabilities in neurofibromatosis. In: AE Rubenstein, BR Korf, eds. Neurofibromatosis: a handbook for patients, families and healthcare professionals. New York: Thieme, 1990: 55–8.
- 25 Dunn DW, Rods KL. Magnetic resonance imaging evaluation of learning difficulties in neurofibromatosis. Neurofibromatosis 1989: 2: 1–5.
- 26 Legius E, Descheemaeker MJ, Spaepen A, Casaer P, Fryns JP. Neurofibromatosis type 1 in childhood: a study of the neuropsychological profile in 45 children. Genetic Counselling 1994: 5(1): 51–60.
- 27 Eliason MJ. Neurofibromatosis: implications for learning and behaviour. J Dev Behav Pediatr 1986: 7: 175–9.
- 28 Ferner RE, Hughes RAC, Weinman J. Intellectual impairment in neurofibromatosis 1. J Neurol Sciences 1996: 138: 125–33.
- 29
Chapman CA,
Waber DP,
Bassett N,
Urion DK,
Korf B.
Neurobehavioral profiles of children with neurofibromatosis 1 referred for learning disabilities are sex-specific.
Am J Med Genetics (Neuropsychiatrie Genetics)
1996: 67: 127–32.
10.1002/(SICI)1096-8628(19960409)67:2<127::AID-AJMG1>3.0.CO;2-P CAS PubMed Web of Science® Google Scholar
- 30 Samuelsson B, Riccardi VM. Neurofibromatosis in Gothenburg, Sweden. II. Intellectual compromise. Neurofibromatosis 1989: 2: 78–83.
- 31 Garty BZ, Laor A, Danon YL. Neurofibromatosis type 1 in Israel: survey of young adults. J Med Genet 1994: 31: 853–7.
- 32 Ballester R, Marchuk D, Boguski M et al. The NF1 locus encodes a protein functionally related to mammalian GAP and yeast IRA proteins. Cell 1990: 63: 851–9.
- 33 Martin GA, Viskochil D, Bollag G et al. The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21. Cell 1990: 63: 843–9.
- 34 Xu G, Lin B, Tanaka K et al. The catalytic domain of the neurofibromatosis type 1 gene product stimulates ras GT-Pase and complements IRA mutants of S. cerevisiae. Cell 1990: 63: 835–41.
- 35 Feldkamp MM, Lau N, Provias JP, Gutmann DH, Guha A. Acute presentation of a neurogenic sarcoma in a patient with neurofibromatosis type 1: a pathological and molecular explanation. J Neurosurg 1996: 84(5): 867–73.
- 36 Daston M. The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells and oligodendrocytes. Neurone 1992: 8: 415–28.
- 37 Guha A, Lau N, Huvar I et al. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors. Oncogene 1996: 12(3): 507–13.
- 38 Gutmann DH, Giordano MJ, Mahadeo DK, Lau N, Silbergeld D, Guha A. Increased neurofibromatosis 1 gene-expression in astrocytic tumors: positive regulation by p21-Ras. Oncogene 1996: 12(10): 2121–7.
- 39 Nordlund ML, Rizvi TA, Brannan CI, Ratner N. Neuro-fibromin expression and astrogliosis in neurofibromatosis (type 1) brains. J Neuropathol Esp Neurol 1995: 54(4): 588–600.
- 40 Duffner PK, Cohen ME, Seidel FG, Shucard DW. The significance of MRI abnormalities in children with neurofibromatosis. Neurology 1989: 39: 373–8.
- 41 Ferner RE, Chaudhuri R, Bingham J, Cox T, Hughes RAC. MRI in neurofibromatosis 1. The nature and evolution of increased intensity T2 weighted lesions and their relationship to intellectual impairment. J Neurol Neurosurg Psychiatry 1993: 56: 492–5.
- 42 Legius E, Descheemaeker MJ, Steyaert J et al. Neurofibromatosis type 1 in childhood: correlation of MRI findings with intelligence. J Neurol Neurosurg Psychiatry 1995: 59(6): 638–40.
- 43 Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996: 46(6): 1660–8.
- 44
Mott S,
Baumgartner T,
Skryja PB et al.
Neurofibromatosis type 1: association between volumes of T2-weighted high intensity signals on MRI and impaired judgement on line orientation.
Pediatr Neurology
1994: 11: 88.
10.1016/0887-8994(94)90170-8 Google Scholar
- 45
Denckla MB,
Hofman K,
Mazzocco MM et al.
Relationship between T2-weighted hyperintensities (unidentified bright objects) and lower IQs in children with neurofibromatosis-1.
Am J Med Genetics
1996: 67: 98–102.
10.1002/(SICI)1096-8628(19960216)67:1<98::AID-AJMG17>3.0.CO;2-K CAS PubMed Web of Science® Google Scholar
- 46 Hofman KJ, Harris EL, Bryan RN, Denckla MB. Neurofibromatosis type 1: the cognitive phenotype. J Pediatr 1994: 124: 1–8.
- 47 Bäckman L, Forsell Y. Episodic memory functioning in a community-based sample of old adults with major depression: utilization of cognitive support. J Abnorm Psychol 1994: 103(2): 361–70.
- 48 Almkvist O, Wahlund L, Andersson-Lundman G, Basun H, Bäckman L. White-matter hyperintensity and neuropsychological functions in dementia and healthy ageing. Arch Neurol 1992: 49: 626–32.
- 49 Shu HH, Mirowitz SA, Wippold FJ. Neurofibromatosis: MR imaging findings involving the head and spine. AJR 1993: 160: 159–64.
- 50 DiPaolo DP, Zimmerman RA, Rorke LB et al. Neurofibromatosis type 1: pathologic substrate of high-signal-intensity foci in the brain. Radiology 1995: 195: 721–4.
- 51 ÅSberg M, Perris C, Schalling D, Sedvall G. The CPRS: development and application of a psychiatric rating scale. Acta Psychiatr Scand 1978: 271(Suppl): 1–69.
- 52 American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Washington, DC: 1987.
- 53 Dureman I, Kebbon L, ÖSterberg E Manual till DS-batteriet. Stockholm: PsykologiFörlaget AB, 1971.
- 54 Reitan RM. A research program on the psychological effects of brain lesions in human beings. In: NR Ellis, ed. New York: Academic Press, 1966: 153–215.
- 55 Benton AL. Revised Visual Retention Test: clinical and experimental applications. The Psychological Corporation Harcourt Brace Jovanovic, Inc. 1974.
- 56 Williams JMG, Watts FN, Macleod C, Mathews A. Cognitive psychology and emotional disorders. New York: Wiley, 1988.
- 57 Lezak MD. Neuropsychological assessment. Oxford: University Press, 1995.
- 58 Sternberg S. Memory scanning: new findings and current controversies. Q J Exp Psychol 1975: 27: 1–32.
- 59
Weingartner H.
Automatic and effort-demanding cognitive processes in depression. Clinical memory assessment of older adults. Washington DC: American Psychological Association, 1986: 218–25.
10.1037/10057-018 Google Scholar
- 60 North K, Joy P, Yuille D et al. Specific learning disability in children with neurofibromatosis type 1. Neurology 1994: 44: 878–83.
- 61 Joy P, Roberts C, North K, De Silva M Neuropsychological function and MRI abnormalities in neurofibromatosis type 1. Dev Med Child Neurol 1995: 37(10): 906–14.
- 62 Itoh T, Magnaldi S, White RM et al. Neurofibromatosis type 1: the evolution of deep gray and white matter MR abnormalities. AJNR Am J Neuroradiol 1994: 15: 1513–19.
- 63 Rosman NP, Pearce J. The brain in multiple neurofibromatosis (von Recklinghausen's disease): a suggested neuropathological basis for the associated mental defect. Brain 1967: 90: 829–38.
- 64 Cummings JL, Benson DF. Dementia: a clinical approach. Boston: Butterworths, 1991.
- 65 Albert ML, Feidman RG, Willis AL. The subcortical dementia of progressive supranuclear palsy. J Neurol Neurosurg Psychiatr 1974: 37: 121–30.
- 66 McHugh PR, Folstein MF. Psychiatric syndromes of Huntington's chorea: a clinical and phenomenologic study. In: DFD Benson, eds. Psychiatric aspects of neurologic disease. New York: Grune & Stratton, 1975.
- 67 Cummings JL. Subcortical dementia. Neuropsychology, neuropsychiatry, and pathophysiology. Br J Psychiatry 1986: 149: 682–97.
